Celsion
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Celsion and buy or sell other stocks, ETFs, and their options commission-free!About CLSN
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies.
CEOStacy R. Lindborg, PhD
CEOStacy R. Lindborg, PhD
Employees25
Employees25
HeadquartersLawrenceville, New Jersey
HeadquartersLawrenceville, New Jersey
Founded1982
Founded1982
Employees25
Employees25
CLSN Key Statistics
Market cap20.27M
Market cap20.27M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume42.37K
Average volume42.37K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$41.22
52 Week high$41.22
52 Week low$3.56
52 Week low$3.56
Stock Snapshot
As of today, Celsion(CLSN) shares are valued at $7.00. The company's market cap stands at 20.27M, with a P/E ratio of -0.38.
On 2025-12-16, Celsion(CLSN) stock opened at —, reached a high of —, and a low of —.
The Celsion(CLSN)'s current trading volume is 0, compared to an average daily volume of 42.37K.
In the last year, Celsion(CLSN) shares hit a 52-week high of $41.22 and a 52-week low of $3.56.
In the last year, Celsion(CLSN) shares hit a 52-week high of $41.22 and a 52-week low of $3.56.
People also own
Based on the portfolios of people who own CLSN. This list is generated using Robinhood data, and it’s not a recommendation.